Abstract:
Introduction. Chronic obstructive pulmonary disease (COPD) is a multifactorial lung disease characterized by irreversible or partially reversible airflow obstruction. Globally, COPD is the third leading cause of death, responsible for approximately 3.2 million deaths annually. It is estimated that in the coming decades, the number of COPD cases will rise to 600 million. Exacerbations play an important role in the pathogenesis and progression of the disease, worsening patients’ quality of life and increasing hospitalizations. In this study, we aimed to investigate the relationship between COPD severity and several blood count-derived inflammatory biomarkers, including the systemic inflammatory index (SII), aggregate systemic inflammation index (AISI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR), to assess the systemic inflammatory response. Aim of study. To evaluate the relationship between AISI, SII, and NLR and the severity of COPD. Methods and materials. We conducted a retrospective observational study analyzing medical records of 56 COPD patients hospitalized in the pulmonology department of IMSP SCM “Sfântul Arhanghel Mihail.” The following parameters were evaluated: age, length of hospitalization, FEV1%, COPD severity classification, and inflammatory indices derived from blood counts (AISI, SII, NLR, LMR). The Spearman rank correlation coefficient was used to analyze associations between variables. Results. The study included 56 patients with a mean age of 66.45 ± 8.9 years. Blood count biomarkers showed a positive correlation with COPD severity, including SII (r = 0.92, p < 0.05), NLR (r = 0.65, p < 0.05), and AISI (r = 0.68, p < 0.05). These findings reflect the association between systemic inflammatory activity and hematological parameters in COPD. A strong negative correlation was observed between FEV1% and COPD severity (r = -0.95, p < 0.05), indicating that reduced lung function is closely linked to increased disease severity. Conclusions. Elevated values of NLR, AISI, and SII highlight the relationship between COPD severity, hospitalization duration, and disease progression. These accessible inflammatory markers may help identify patients at higher risk of worsening and support management and treatment decisions.